Literature DB >> 16434208

The genetics of HNPCC: application to diagnosis and screening.

Wael M Abdel-Rahman1, Jukka-Pekka Mecklin, Päivi Peltomäki.   

Abstract

Hereditary nonpolyposis colorectal cancer syndrome (HNPCC; Lynch Syndrome) is the most common form of hereditary colorectal cancers. Predisposed individuals have increased lifetime risk of developing colorectal, endometrial and other cancers. The syndrome is primarily due to heterozygous germline mutations in one of the mismatch repair genes; mainly MLH1, MSH2, MSH6 and PMS2. The resulting mismatch repair deficiency leads to microsatellite instability which is the hallmark of tumors arising within this syndrome, as well as a variable proportion of sporadic tumors. Diagnostic guidelines and criteria for molecular testing of suspected families have been proposed and are continuously updated. However, not all families fulfilling these criteria show mutations in mismatch repair genes and/or microsatellite instability implicating other, as yet unknown, carcinogenic mechanisms and predisposition genes. This subset of tumors is the focus of current clinical and molecular research. This review addresses recent advances in the field of HNPCC research and their applications in the management of affected individuals and families.

Entities:  

Mesh:

Year:  2006        PMID: 16434208     DOI: 10.1016/j.critrevonc.2005.11.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  27 in total

1.  Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors:  R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

2.  Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.

Authors:  Tanya-Kirilova Kadiyska; Radka-Petrova Kaneva; Dimitar-Georgiev Nedin; Alexandrina-Borisova Alexandrova; Antonina-Todorova Gegova; Stoyan-Ganchev Lalchev; Tatyana Christova; Vanio-Ivanov Mitev; Juergen Horst; Nadja Bogdanova; Ivo-Marinov Kremensky
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Authors:  Johanna Kondelin; Sari Tuupanen; Alexandra E Gylfe; Mervi Aavikko; Laura Renkonen-Sinisalo; Heikki Järvinen; Jan Böhm; Jukka-Pekka Mecklin; Claus L Andersen; Pia Vahteristo; Esa Pitkänen; Lauri A Aaltonen
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

Review 4.  Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?

Authors:  Fränzel J B van Duijnhoven; Akke Botma; Renate Winkels; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy.

Authors:  Wakkas Fadhil; Karin Kindle; Darryl Jackson; Abed Zaitoun; Nina Lane; Adrian Robins; Mohammad Ilyas
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

6.  Uroepithelial and kidney carcinoma in Lynch syndrome.

Authors:  Markku Aarnio; Matti Säily; Matti Juhola; Annette Gylling; Päivi Peltomäki; Heikki J Järvinen; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 7.  [Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].

Authors:  R Büttner; N Friedrichs
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

8.  Genomic instability and carcinogenesis: an update.

Authors:  Wael M Abdel-Rahman
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

9.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

10.  MSH6 syndrome.

Authors:  Janina Suchy; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.